Siqi Wu

458 total citations
14 papers, 341 citations indexed

About

Siqi Wu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Siqi Wu has authored 14 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cancer Research and 3 papers in Immunology. Recurrent topics in Siqi Wu's work include Circular RNAs in diseases (9 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (4 papers). Siqi Wu is often cited by papers focused on Circular RNAs in diseases (9 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (4 papers). Siqi Wu collaborates with scholars based in China. Siqi Wu's co-authors include Chen Yang, Xinan Chen, Haowen Jiang, Yuxi Ou, Xiyu Dai, Zezhong Mou, Yiling Chen, Chenyang Xu, Shengming Jin and Zheyu Zhang and has published in prestigious journals such as Advanced Science, Molecular Therapy and Cell Death and Disease.

In The Last Decade

Siqi Wu

14 papers receiving 337 citations

Peers

Siqi Wu
Xiufeng Xie China
Sang Yean Kim South Korea
Qiang Zhan China
Zuoming Xu China
Miao Chen China
Hu Zhou China
Renpeng Xia China
Yaozhou He China
Jun-Xian Du China
Xiufeng Xie China
Siqi Wu
Citations per year, relative to Siqi Wu Siqi Wu (= 1×) peers Xiufeng Xie

Countries citing papers authored by Siqi Wu

Since Specialization
Citations

This map shows the geographic impact of Siqi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siqi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siqi Wu more than expected).

Fields of papers citing papers by Siqi Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siqi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siqi Wu. The network helps show where Siqi Wu may publish in the future.

Co-authorship network of co-authors of Siqi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Siqi Wu. A scholar is included among the top collaborators of Siqi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siqi Wu. Siqi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Xiong, Jiaqiang, Hanxiao Xu, Qiuji Wu, et al.. (2025). CpG‐Based Nanovaccines Enhance Ovarian Cancer Immune Response by Gbp2‐Mediated Remodeling of Tumor‐Associated Macrophages. Advanced Science. 12(15). e2412881–e2412881. 4 indexed citations
2.
3.
Dai, Xiyu, Xinan Chen, Yuxi Ou, et al.. (2023). CircDHRS3 inhibits prostate cancer cell proliferation and metastasis through the circDHRS3/miR-421/MEIS2 axis. Epigenetics. 18(1). 2178802–2178802. 12 indexed citations
4.
Yang, Chen, et al.. (2022). Silencing circFTO inhibits malignant phenotype through modulating DUSP4 expression in clear cell renal cell carcinoma. Cell Death Discovery. 8(1). 392–392. 5 indexed citations
5.
Ou, Yuxi, Xiyu Dai, Xinan Chen, et al.. (2022). Circ-AFAP1 promote clear cell renal cell carcinoma growth and angiogenesis by the Circ-AFAP1/miR-374b-3p/VEGFA signaling axis. Cell Death Discovery. 8(1). 68–68. 15 indexed citations
6.
Yang, Chen, Siqi Wu, Zezhong Mou, et al.. (2022). Exosome-derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments. Molecular Therapy. 30(3). 1054–1070. 127 indexed citations
7.
Yang, Chen, Zezhong Mou, Siqi Wu, et al.. (2021). High-throughput sequencing identified circular RNA circUBE2K mediating RhoA associated bladder cancer phenotype via regulation of miR-516b-5p/ARHGAP5 axis. Cell Death and Disease. 12(8). 22 indexed citations
8.
Yang, Chen, Zezhong Mou, Zheyu Zhang, et al.. (2021). Circular RNA RBPMS inhibits bladder cancer progression via miR-330-3p/RAI2 regulation. Molecular Therapy — Nucleic Acids. 23. 872–886. 36 indexed citations
9.
Zhang, Zheyu, Zezhong Mou, Chenyang Xu, et al.. (2021). Autophagy-associated circular RNA hsa_circ_0007813 modulates human bladder cancer progression via hsa-miR-361-3p/IGF2R regulation. Cell Death and Disease. 12(8). 778–778. 29 indexed citations
10.
Yang, Chen, Siqi Wu, Zezhong Mou, et al.. (2021). Transcriptomic Analysis Identified ARHGAP Family as a Novel Biomarker Associated With Tumor-Promoting Immune Infiltration and Nanomechanical Characteristics in Bladder Cancer. Frontiers in Cell and Developmental Biology. 9. 657219–657219. 12 indexed citations
11.
Chen, Qi, Zheyu Zhang, Siqi Wu, et al.. (2020). Hsa_circ_0068307 mediates bladder cancer stem cell-like properties via miR-147/c-Myc axis regulation. Cancer Cell International. 20(1). 151–151. 24 indexed citations
12.
Mou, Zezhong, Chen Yang, Zheyu Zhang, et al.. (2020). Transcriptomic Analysis of Glycolysis-Related Genes Reveals an Independent Signature of Bladder Carcinoma. Frontiers in Genetics. 11. 566918–566918. 7 indexed citations
13.
Chen, Yang, Zheyu Zhang, Fangdie Ye, et al.. (2020). FGF18 Inhibits Clear Cell Renal Cell Carcinoma Proliferation and Invasion via Regulating Epithelial-Mesenchymal Transition. Frontiers in Oncology. 10. 1685–1685. 11 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiufeng Xie Breakdown of academic impact, for papers by Sang Yean Kim Breakdown of academic impact, for papers by Qiang Zhan Breakdown of academic impact, for papers by Zuoming Xu Breakdown of academic impact, for papers by Miao Chen Breakdown of academic impact, for papers by Hu Zhou Breakdown of academic impact, for papers by Renpeng Xia Breakdown of academic impact, for papers by Yaozhou He Breakdown of academic impact, for papers by Jun-Xian Du
Rankless by CCL
2026